• 1
    Bacon BR, Powell L, Adams PC, Kresina T, Hoofnagle J. Molecular medicine and hemochromatosis: at the crossroads. Gastroenterology 1999; 116:193207.MEDLINE
  • 2
    Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A, Dormishian F, et al. A novel MHC class I-like gene is mutated in patients with hereditary hemochromatosis. Nature Genetics 1996; 13:399408.MEDLINE
  • 3
    Burke W, Thomson E, Khoury M, McDonnell S, Press N, Adams P, Barton J, et al. Hereditary hemochromatosis: gene discovery and its implications for population-based screening. JAMA 1998; 280:172178.MEDLINE
  • 4
    Gambino R, Desvarieux E, Orth M, Matan H, Ackattupathil T, Lijoi E, Wimmer C, et al. The relation between chemically measure total iron-binding capacity concentrations and immunologically measured transferrin concentrations in human serum. Clin Chem 1997; 43:24082412.MEDLINE
  • 5
    Adams PC, Chakrabarti S. Genotypic/phenotypic correlations in genetic hemochromatosis: evolution of diagnostic criteria. Gastroenterology 1998; 114:319323.MEDLINE
  • 6
    Jeffrey G, Chakrabarti S, Hegele R, Adams PC. Polymorphism in intron 4 of HFE may cause overestimation of C282Y homozygote prevalence in haemochromatosis. Nat Genet 1999; 22:325326.MEDLINE
  • 7
    Pellar TG, Galbraith L, Leung F, Henderson AR. A computer program to determine diagnostic decision thresholds and likelihood ratios illustrated with aspartate aminotransferase activities after a myocardial infarction. Ann Clin Biochem 1989; 26:533537.MEDLINE
  • 8
    Henderson AR. Assessing test accuracy and its clinical consequences: a primer for receiver operating characteristic curve analysis. Ann Clin Biochem 1993; 30:521539.MEDLINE
  • 9
    Pellar TG, Leung FY, Henderson AR. A computer program for rapid generation of receiver operating characteristic curves and likelihood ratios in the evaluation of diagnostic tests. Ann Clin Biochem 1988; 25:411416.MEDLINE
  • 10
    Jaeschke R, Guyatt G, Sackett DL. User's guide to the medical literature. III. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients? JAMA 1994; 271:703707.MEDLINE
  • 11
    Guyader D, Jacquelinet C, Moirand R, Turlin B, Mendler M, Chaperon J, David V, et al. Non-invasive prediction of fibrosis in C282Y homozygous hemochromatosis. Gastroenterology 1998; 115:929936.MEDLINE
  • 12
    Moirand R, Jouanolle A-M, Brissot P, Le Gall J-Y, David V, Deugnier Y. Phenotypic expression of HFE mutations: a French study of 1110 unrelated iron-overloaded patients and relatives. Gastroenterology 1999; 116:372377.MEDLINE
  • 13
    David V, Moirand R, LeGall J-Y, Deugnier Y, Jouanolle AM. Preliminary studies before systematic screening of hemochromatosis: prevalence and penetrance of C282Y homozygosity [Abstract]. Am J Hum Genet 1999; 65:A213.
  • 14
    Olynyk J, Cullen D, Aquilia S, Rossi E, Summerville L, Powell LW. A population-based study of the clinical expression of the hemochromatosis gene. N Eng J Med 1999; 341:718724.
  • 15
    Adams PC. Population screening for hemochromatosis. Hepatology 1999; 29:13241327.MEDLINE
  • 16
    Phatak P, Sham R, Rabuertas R, Dunnigan K, O'Leary M, Braggins C, Cappuccio J. Prevalence of hereditary hemochromatosis in a sample of 16,031 primary care patients. Ann Int Med 1998; 129:954961.
  • 17
    Baer DM, Simons JL, Staples RL, Rumore GJ, Morton CJ. Hemochromatosis screening in asymptomatic ambulatory men 30 years of age and older. Am J Med 1995; 98:464468.MEDLINE
  • 18
    Edwards CQ, Griffen LM, Goldgar D, Drummond C, Skolnick MH, Kushner JP. Prevalence of hemochromatosis among 11,065 presumably healthy blood donors. N Engl J Med 1988; 318:13551362.MEDLINE
  • 19
    Niederau C, Niederau CM, Lange S, Littauer A, Abdel-Jalil N, Maurer M, Haussinger D, et al. Screening for hemochromatosis and iron deficiency in employees and primary care patients in Western Germany. Ann Int Med 1998; 128:337345.
  • 20
    Smith BN, Kantrowitz W, Grace ND, Greenberg MS, Patton TJ, Ookubo R, Sorger K, et al. Prevalence of hereditary hemochromatosis in a Massachusetts corporation: Is Celtic origin a risk factor? Hepatology 1997; 25:14391446.MEDLINE
  • 21
    McLaren C, McLauchlan G, Halliday JW, Webb S, Leggett BA, Jazwinska E, Crawford D, et al. Distribution of transferrin saturation in an Australian population: relevance to early diagnosis of hemochromatosis. Gastroenterology 1998; 114:543549.MEDLINE
  • 22
    Adams PC, Kertesz A, Valberg LS, Chakrabarti S. Sensitivity of transferrin saturation and ferritin in the diagnosis of hemochromatosis is highly dependent on the population sample [Abstract]. Hepatology 1998; 28:617A.
  • 23
    Edwards CQ, Griffen LM, Kaplan J, Kushner JP. Twenty-four hour variation of transferrin saturation in treated and untreated haemochromatosis homozygotes. J Intern Med 1989; 226:373379.MEDLINE
  • 24
    McDonnell S, Phatak P, Felitti V, McLaren G. Screening for hemochromatosis in primary care setttings. Ann Int Med 1998; 129:962970.
  • 25
    Adams PC, Gregor JC, Kertesz AE, Valberg LS. Screening blood donors for hereditary hemochromatosis: decision analysis model based on a thirty-year database. Gastroenterology 1995; 109:177188.MEDLINE
  • 26
    Adams PC, Valberg LS. Screening blood donors for hereditary hemochromatosis: decision analysis model comparing genotyping to phenotyping. Am J Gastroenterology 1999; 94:15931600.
    Direct Link:
  • 27
    Hickman P, Hourigan L, Powell LW, Cordingley F, Dimenski G, Ormiston B, Shaw J, et al. Automated measurement of unsaturated iron binding capacity is an effective screening strategy for C282Y homozygous haemochromatosis. Gut 2000; 46:405409.MEDLINE
  • 28
    Witte D. Mild liver enzyme abnormalities: eliminating hemochromatosis as cause. Clin Chem 1997; 43:15351538.MEDLINE